Current Cardiology Reports

Article	Citations
Sepsis-Induced Cardiomyopathy: a Comprehensive Review	138
Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies	135
Outcomes in Patients with COVID-19 Infection Taking ACEI/ARB	125
Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response	115
The Role of Anticoagulation in COVID-19-Induced Hypercoagulability	85
Cardiac Tumors: Diagnosis, Prognosis, and Treatment	80
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19	48
Management of Arrhythmias Associated with COVID-19	48
Point-of-Care Ultrasound	47
Burnout Among Women Physicians: a Call to Action	45
Promise and Perils of Telehealth in the Current Era	42
Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment	42
Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty	42
Non-HDL Cholesterol or apoB: Which to Prefer as a Target for the Prevention of Atherosclerotic Cardiovascular Disease?	41
Mineralocorticoid Receptor Antagonists: a Comprehensive Review of Finerenone	39
Familial Hypercholesterolemia: Global Burden and Approaches	38
Ischemic Cardiomyopathy and Heart Failure After Acute Myocardial Infarction	38
Pericardial Diseases in COVID19: a Contemporary Review	38
Mechanisms and Treatment of Dyslipidemia in Diabetes	38
Home Monitoring of Cardiac Devices in the Era of COVID-19	36
Heart Failure with Preserved Ejection Fraction—a Concise Review	36
Complications Following MitraClip Implantation	36
Immunotherapy-Associated Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T Cell Therapy: Diagnostic and Management Challenges and Strategies	35
What Is the Role of the Inflammation in the Pathogenesis of Heart Failure?	34
Cardiac Rehabilitation: Under-Utilized Globally	33

18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization	32
Mechanisms Driving Immune-Related Adverse Events in Cancer Patients Treated with Immune Checkpoint Inhibitors	32
Novel Pharmacotherapies for Recurrent Pericarditis: Current Options in 2020	31
5-FU Cardiotoxicity: Vasospasm, Myocarditis, and Sudden Death	30
Psychological aspects of atrial fibrillation: A systematic narrative review	30
The Role of Artificial Intelligence in Echocardiography	30
Remote monitoring and telemedicine in heart failure: implementation and benefits	28
Cardiac Regeneration After Myocardial Infarction: an Approachable Goal	27
State-of-the-Art of Endomyocardial Biopsy on Acute Myocarditis and Chronic Inflammatory Cardiomyopathy	27
Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets	26
COVID-19 and Cardiovascular Disease: a Global Perspective	26
Mechanisms of Neonatal Heart Regeneration	25
Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)	25
Associations of Glycemic Index and Glycemic Load with Cardiovascular Disease: Updated Evidence from Meta-analysis and Cohort Studies	24
Diagnosis and Management of Lymphatic Disorders in Congenital Heart Disease	24
Artificial Intelligence-Enabled ECG: a Modern Lens on an Old Technology	23
Psychological Preparation for Cardiac Surgery	23
Machine Learning and Coronary Artery Calcium Scoring	23
Artificial Intelligence in Intracoronary Imaging	22
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension?	22
Ultrasonography in the Critical Care Unit	22
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities	22
Pericarditis in Systemic Rheumatologic Diseases	22
Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation	22
Loneliness and Risk for Cardiovascular Disease: Mechanisms and Future Directions	21
Wnt Signaling in Heart Development and Regeneration	21
Medication Non-adherence: a Major Cause of Resistant Hypertension	21
Comprehensive Care Models for Cardiometabolic Disease	21
Relief of Ischemia in Ischemic Cardiomyopathy	20
Improving Quality of Life in Heart Failure	20
Metabolic Syndrome and Cognitive Function	20
Artificial Intelligence and Texture Analysis in Cardiac Imaging	19
Targeting Inflammation After Myocardial Infarction	19
Ethnic and Racial Disparities in Acute Myocardial Infarction	18
Clinical Utility of Echocardiographic Strain and Strain Rate Measurements	18
Vericiguat for Heart Failure with Reduced Ejection Fraction	18
The Sarcomeric Spring Protein Titin: Biophysical Properties, Molecular Mechanisms, and Genetic Mutations Associated with Heart Failure and Cardiomyopathy	18
Myocarditis: Which Role for Genetics?	18
Role of Exercise as a Modulating Factor in Arrhythmogenic Cardiomyopathy	17
Therapeutic Approach to Calcified Coronary Lesions: Disruptive Technologies	17
Mavacamten, a Novel Therapeutic Strategy for Obstructive Hypertrophic Cardiomyopathy	17
Detection of Native and Prosthetic Valve Endocarditis: Incremental Attributes of Functional FDG PET/CT over Morphologic Imaging	17
Autoimmunity in Acute Myocarditis: How Immunopathogenesis Steers New Directions for Diagnosis and Treatment	17
Multimodality Imaging for Cardiac Evaluation in Patients with COVID-19	16
Heart and Brain: Complex Relationships for Left Ventricular Dysfunction	16
Sex-Specific Plaque Signature: Uniqueness of Atherosclerosis in Women	16
SARS-CoV-2 Myocarditis: Insights Into Incidence, Prognosis, and Therapeutic Implications	16
Overview of Optimal Techniques for Pericardiocentesis in Contemporary Practice	16
How Much Lowering of Blood Pressure Is Required to Prevent Cardiovascular Disease in Patients With and Without Previous Cardiovascular Disease?	16
Left Ventricular Noncompaction Syndrome: Genetic Insights and Therapeutic Perspectives	16

Updates in Spontaneous Coronary Artery Dissection	16
Diabetes and the Risk of Sudden Cardiac Death	16
Echo-Guided Pericardiocentesis: When and How Should It Be Performed?	16
Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy	15
New Recommendations and Revised Concepts in Recent Guidelines on the Management of Dyslipidemias to Prevent Cardiovascular Disease: the 2018 ACC/AHA and 2019 ESC/EAS Guidelines	15
Is Sedentary Behavior a Novel Risk Factor for Cardiovascular Disease?	15
New Approaches to Management of Pericardial Effusions	15
Epidemiology of Type 1 Diabetes	15
Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems	15
The PASCAL Device—Early Experience with a Leaflet Approximation Device: What Are the Benefits/Limitations Compared with the MitraClip?	15
Diagnosis and Management of Acute Aortic Syndromes: Dissection, Penetrating Aortic Ulcer, and Intramural Hematoma	15
High-Sensitivity Troponins in Cardiovascular Disease	14
Correction to: Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response	14
Drug Repurposing: Claiming the Full Benefit from Drug Development	14
Left Bundle Branch Area Pacing: Implant Technique, Definitions, Outcomes, and Complications	14
Cusp Overlap Technique: Should It Become the Standard Implantation Technique for Self-expanding Valves?	14
Shock to the Heart: Psychosocial Implications and Applications of Sudden Cardiac Death in the Young	14
Does Timing of Antihypertensive Medication Dosing Matter?	13
Olive Oil Intake and Cardiovascular Disease Prevention: “Seek and You Shall Find”	13
Atrial Fibrillation and Cancer Patients: Mechanisms and Management	13
The Role of Carotid and Femoral Plaque Burden in the Diagnosis of Coronary Artery Disease	13
Cardiovascular Toxicity of Androgen Deprivation Therapy	13
Imaging-Guided Treatment for Cardiac Amyloidosis	13
Acute Pericarditis: Update	13
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection	13
Role of Mononuclear Cardiomyocytes in Cardiac Turnover and Regeneration	13
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021	13
Update on the Inflammatory Hypothesis of Coronary Artery Disease	13
Sinus Venosus ASDs: Imaging and Percutaneous Closure	13
TAVR in Patients with Pure Aortic Regurgitation: Ready to Use?	13
Physical Activity and Cardiorespiratory Fitness: Vital Signs for Cardiovascular Risk Assessment	13
Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease	13
Beyond Sarcomeric Hypertrophic Cardiomyopathy: How to Diagnose and Manage Phenocopies	13
The Global Impact of Rheumatic Heart Disease	13
Recent Advances in T1 and T2 Mapping in the Assessment of Fulminant Myocarditis by Cardiac Magnetic Resonance	13
Angiography-Based Fractional Flow Reserve: State of the Art	12
Influenza Vaccination for Cardiovascular Prevention: Further Insights from the IAMI Trial and an Updated Meta-analysis	12
Cardiovascular Disease Amongst Women Treated for Breast Cancer: Traditional Cytotoxic Chemotherapy, Targeted Therapy, and Radiation Therapy	12
The Role of B Cells in Cardiomyopathy and Heart Failure	12
Pulsed Field Ablation: a New Paradigm for Catheter Ablation of Arrhythmias	11
Role of Clinical Genetic Testing in the Management of Aortopathies	11
Sleep and Circadian Disturbance in Cardiovascular Risk	11
The Promise and Peril of Vaping	11
The Role of Autoantibodies in Arrhythmogenesis	11
Disorders of the Aorta and Aortic Valve in Connective Tissue Diseases	11
Intimate Relationships and Coronary Heart Disease: Implications for Risk, Prevention, and Patient Management	11
Biventricular Conversion in the Borderline Hypoplastic Heart	11
Machine Learning in Electrocardiography and Echocardiography: Technological Advances in Clinical Cardiology	11
Effects of Psychological Stress on Vascular Physiology: Beyond the Current Imaging Signal	11
Incremental Value of FDG-PET in the Evaluation of Cardiac Masses	11
PET Tracers for Imaging Cardiac Function in Cardio-oncology	11
Metabolic Regulation of Human Pluripotent Stem Cell-Derived Cardiomyocyte Maturation	11
Mental Stress-Induced Myocardial Ischemia	11
Advances in PET-Based Cardiac Amyloid Radiotracers	11
COVID’s Impact on Non-communicable Diseases: What We Do Not Know May Hurt Us	10
A Change of Heart: Human Cardiac Tissue Engineering as a Platform for Drug Development	10
Role of Cardiac Fibroblasts in Cardiac Injury and Repair	10
Pheochromocytoma and Paraganglioma in Pregnancy: a New Era	10
Approach to Hypertension in Adolescents and Young Adults	10
Use of Polygenic Risk Scores for Coronary Heart Disease in Ancestrally Diverse Populations	10
Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification	10
Sudden Cardiac Death Prediction in Non-ischemic Dilated Cardiomyopathy: a Multiparametric and Dynamic Approach	10
Cardiovascular Magnetic Resonance Imaging and Heart Failure	10
Intersection Between Chronic Kidney Disease and Cardiovascular Disease	10
Cardiac Outpatient Care in a Digital Age: Remote Cardiology Clinic Visits in the Era of COVID-19	10
Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk	10
Diagnostic and Management Dilemmas in Women Presenting with Acute Coronary Syndromes	10
Treatment of Congenital and Acquired Pulmonary Vein Stenosis	10
The Cardiovascular Effects of Electronic Cigarettes	10
Omega-3 Fatty Acids in Cardiovascular Disease and Diabetes: a Review of Recent Evidence	10
Management of Patients with Acute Coronary Syndrome and Cancer	10
Radiomics in Echocardiography: Deep Learning and Echocardiographic Analysis	10
Quantification of Myocardial Mitochondrial Membrane Potential Using PET	9
Therapeutic Outcomes with Surgical and Medical Management of Primary Aldosteronism	9
Management of Cardiovascular Health in People with Severe Mental Disorders	9
Updates in Cerebral Venous Thrombosis	9
The Riskier Lipid: What Is on the HORIZON for Lipoprotein (a) and Should There Be Lp(a) Screening for All?	9
SAMSON and the Nocebo Effect: Management of Statin Intolerance	9
MRI-Guided Cardiac Catheterization in Congenital Heart Disease: How to Get Started	9
ACURATE neo: How Is This TAVR Valve Doing to Fit into an Increasingly Crowded Field?	9

Optimal Detection of Acute Myocardial Injury and Infarction with Cardiac Troponin: Beyond the 99th Percentile, into the High-Sensitivity Era	9
Continuous Glucose Monitor, Insulin Pump, and Automated Insulin Delivery Therapies for Type 1 Diabetes: An Update on Potential for Cardiovascular Benefits	9
Hypertrophic Cardiomyopathy 2020	9
The Role of Behavioral Economics in Improving Cardiovascular Health Behaviors and Outcomes	9
HIV and Global Cardiovascular Health	9
Advances in the Genetics and Genomics of Heart Failure	9
Athletes and Hypertension	9
Sex-Related Differences in Dilated Cardiomyopathy with a Focus on Cardiac Dysfunction in Oncology	9
Cerebral Protection Devices during Transcatheter Interventions: Indications, Benefits, and Limitations	9
Racial and Ethnic Disparities in Hypertension: Barriers and Opportunities to Improve Blood Pressure Control	9
Stroke Prevention After Cryptogenic Stroke	9
Aging Hearts in a Hotter, More Turbulent World: The Impacts of Climate Change on the Cardiovascular Health of Older Adults	9
Cardiac Rehabilitation and Survival for Ischemic Heart Disease	9
Evolution of Patiromer Use: a Review	9
PET Radiopharmaceuticals for Imaging Chemotherapy-Induced Cardiotoxicity	8
A Clinician’s Guide to Smartwatch “Interrogation”	8
Acute Cardiorenal Syndrome in Heart Failure: from Dogmas to Advances	8
Pericarditis and Post-cardiac Injury Syndrome as a Sequelae of Acute Myocardial Infarction	8
Role of Telemedicine in Prehospital Stroke Care	8
Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?	8
Sarcoid Heart Disease: an Update on Diagnosis and Management	8
Atrioventricular Septal Defects: Pathology, Imaging, and Treatment Options	8
Evolution and Outcomes of Premature Coronary Artery Disease	8
Air Pollution and the Heart: Updated Evidence from Meta-analysis Studies	8
Icosapent Ethyl: Niche Drug or for the Masses?	8
Prevention of Atherosclerotic Cardiovascular Disease in Childhood	8
Myocardial Fatigue: a Mechano-energetic Concept in Heart Failure	8
Ebstein’s Anomaly of the Tricuspid Valve: an Overview of Pathology and Management	8
Pregnancy-Associated Myocardial Infarction: A Review of Current Practices and Guidelines	8
Monogenic and Polygenic Models of Coronary Artery Disease	8
Cardiac Cell Therapy with Pluripotent Stem Cell-Derived Cardiomyocytes: What Has Been Done and What Remains to Do?	8
Cardiac Manifestations of Post-Acute COVID-19 Infection	8
Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk	8
Selection of PET Camera and Implications on the Reliability and Accuracy of Absolute Myocardial Blood Flow Quantification	8
COVID-19 Vaccine–Related Myocardial and Pericardial Inflammation	8
COVID-19 and Cardiovascular Health Among Patients with Cancer	8
Heart Transplant Donor Selection Guidelines: Review and Recommendations	7
New Insights into the Role of Visit-to-Visit Glycemic Variability and Blood Pressure Variability in Cardiovascular Disease Risk	7
Treatment of Bicuspid Aortic Valve Stenosis with TAVR: Filling Knowledge Gaps Towards Reducing Complications	7
Leadless Pacing: Where We Currently Stand and What the Future Holds	7
Barbershop Management of Hypertension in the African American Population: Pitfalls and Opportunities for Extension to Other Underserved Communities	7
Emerging Genotype–Phenotype Associations in Dilated Cardiomyopathy	7
Health Disparities Across the Continuum of ASCVD Risk	7
Can Sound Public Health Policies Stem the Tide of Burgeoning Epidemic of Cardiovascular Disease in South Asians?	7
Recent Advances in Serum Biomarkers for Risk Stratification and Patient Management in Cardio-Oncology	7
Multimodality Imaging of Constrictive Pericarditis: Pathophysiology and New Concepts	7
How Does COVID-19 Affect the Heart?	7
Erdheim-Chester Disease: a Rare but Important Cause of Recurrent Pericarditis	7
Cost-effectiveness and Outcomes with Early or Same-Day Discharge After Elective Percutaneous Coronary Intervention	7
Autoimmune and Autoinflammatory Pericarditis: Definitions and New Treatments	7
The Impact of Alcohol Intake on Atrial Fibrillation	7
Is Isolated Diastolic Hypertension an Important Phenotype?	7
Psychological Distress After Sudden Cardiac Arrest and Its Impact on Recovery	7
Reprogramming of Non-myocytes into Cardiomyocyte-like Cells: Challenges and Opportunities	7
Direct Oral Anticoagulant Use in Special Populations: Elderly, Obesity, and Renal Failure	7
Clinical Implications of the Genetic Architecture of Dilated Cardiomyopathy	7
Titin-related Cardiomyopathy: Is it a Distinct Disease?	7
Is Optimism a Protective Factor for Cardiovascular Disease?	7
Machine Learning-Based Segmentation of Left Ventricular Myocardial Fibrosis from Magnetic Resonance Imaging	7
Update on MRI Techniques for Evaluation of Pericardial Disease	7
Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis	7
AngioVac for Minimally Invasive Removal of Intravascular and Intracardiac Masses: a Systematic Review	7
Kidney Is Essential for Blood Pressure Modulation by Dietary Potassium	7
A Roadmap to Heart Regeneration Through Conserved Mechanisms in Zebrafish and Mammals	7
Novel Nutritional and Dietary Approaches to Weight Loss for the Prevention of Cardiovascular Disease: Ketogenic Diet, Intermittent Fasting, and Bariatric Surgery	6
Acquisition, Processing, and Interpretation of PET 18F-FDG Viability and Inflammation Studies	6
Keto is Trending: Implications for Body Weight and Lipid Management	6
Bioresorbable Scaffolds in Percutaneous Coronary Intervention: Facing Old Problems, Raising New Hopes	6
Disparities in Cardio-oncology: Effects On Outcomes and Opportunities for Improvement	6
BNP and NT-proBNP Interpretation in the Neprilysin Inhibitor Era	6
Role of Catheter Ablation for Ventricular Arrhythmias in Brugada Syndrome	6
Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs	6
Paravalvular Leak Assessment: Challenges in Assessing Severity and Interventional Approaches	6
Walk with a Doc—a Call to Action for Physician-Led Walking Programs	6
Caregiver Distress and Coronary Artery Disease: Prevalence, Risk, Outcomes, and Management	6
Closed-Loop Artificial Pancreas Therapy for Type 1 Diabetes	6
The Role of Nurse Practitioners in the Management of Heart Failure Patients and Programs	6
Autoimmune Pericarditis: Multimodality Imaging	6
Four Dimensions of the Cardiac Myocyte Epigenome: from Fetal to Adult Heart	6
Cardiovascular Outcome Trials with Glucose-Lowering Drugs	6
The Price of Progress: Cost, Access, and Adoption of Novel Cardiovascular Drugs in Clinical Practice	6
Electrophysiologic Implications of Transcatheter Aortic Valve Replacement: Incidence, Outcomes, and Current Management Strategies	6
Challenges and Controversies in the Management of ACS in Elderly Patients	6
Current Status of Catheter-based Mitral Valve Replacement	6
Updates in the Impact of Chronic Systemic Inflammation on Vascular Inflammation by Positron Emission Tomography (PET)	6
Cardiovascular Toxicities Associated with Tyrosine Kinase Inhibitors	6
Appropriate Use Criteria for Echocardiography in the Era of Value-Based Care: Mission Accomplished or Future Mandates?	6
Treatment of Iron Deficiency in Heart Failure	6
The Imaging Toolbox to Assess Patients with Suspected Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA)	6
Echocardiography in the Era of COVID-19: Lessons for the Future	6
Aspirin, Statins, and Primary Prevention: Opportunities for Shared Decision Making in the Face of Uncertainty	6
Beyond Statins and PCSK9 Inhibitors: Updates in Management of Familial and Refractory Hypercholesterolemias	6
Diabetes and Cardiovascular Complications: The Epidemics Continue	6
Primary Aldosteronism: a Continuum from Normotension to Hypertension	6
The Use of Subclinical Atherosclerosis Imaging to Guide Preventive Cardiology Management	6